ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 925

Complement C5a Receptor Is the Key Initiator of Neutrophil Adhesion and Inflammation in Immune Complex-Induced Arthritis

Yoshishige Miyabe1, Chie Miyabe1, Thomas Murooka2, Edward Kim3, Nancy Kim3, Thorsten R. Mempel4 and Andrew D. Luster1, 1Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2University of Manitoba, Winnipeg, MB, Canada, 3Massachusetts General Hospital, Boston, MA, 4Massachusetts General Hospital, Charlestown, MA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Arthritis, Chemokine Receptors, complement and neutrophils

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis I

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Inflammatory arthritis, including rheumatoid arthritis, is characterized by neutrophil (PMN) recruitment into the joint in a highly regulated process controlled by chemoattractants (CAs). Four different chemoattractant receptors (CAR), BLT1, CCR1, CXCR2 and C5aR, are required and collaborate to mediate PMN recruitment into the joint in immune-complex (IC) induced arthritis. However, the precise role for each CA in the process of PMN recruitment into the joint in vivo remains unclear. This process begins with the capture of free-flowing leukocytes to the vessel wall, followed by rolling and then arrest on the vessel wall, release from adhesion and then crawling in all directions on the vessel to locate a receptive location for transendothelial migration (TEM) into the joint.

Methods: Multiphoton intravital imaging (MP-IVM) was performed to analyze the migratory behavior of wild-type (WT) and CAR-deficient (KO) PMNs in the joint of WT and CAR-KO-LysM-GFP mice, in which endogenous PMNs and macrophages express GFP, on day 7 after K/BxN serum transfer (KST). We analyzed the ability of WT and CAR-KO PMNs to enter the joint in short term adoptive transfer assays on day 7 after KST. We also analyzed joint tissue for the expression of C5a using immunohistochemistry and synovial fluid (SF) for the levels of CKs by ELISA. We analyzed the expression of CARs by flow cytometry on PMNs isolated from the bone marrow (BM), blood and SF. Lastly, we generated mixed bone marrow chimeric (BMC) mice with WT and CAR-KO BM cells transferred into lethally irradiated WT mice to analyze PMN recruitment into the joint through the entire course of arthritis development. Finally, the effect of CXCR2 ligands on SF PMN survival was evaluated.

Results: In the inflamed joint of WT- LysM-GFP mice, abundant PMN adhesion and TEM was observed. However, PMN adhesion and TEM were not observed in the joint of C5aR-KO-LysM-GFP mouse. PMN adhesion was observed in the joints of BLT1-KO-, CCR1-KO- and CXCR2-KO-LysM-GFP mice but PMN TEM was either not observed or was markedly diminished. Short term adoptive transfer assays demonstrated a decrease in the adhesion and TEM of C5aR-KO PMNs, whereas BLT1-KO, CCR1-KO and CXCR2-KO PMNs were able to adhere to the endothelium but had a decrease in TEM into the inflamed joint. 40% adoptively transferred C5aR-KO PMNs that arrested on the endothelium detached, while 20% of CCR1-KO PMNs that crawled on the endothelium detached. WT arrested and crawling PMNs were not observed to detach from the endothelium. C5a deposition was observed on the endothelium and cartilage in arthritic joints. C5a was detected in the joint on day 1, whereas the other CAs were detected at later time points. In mixed BMC mice with arthritis, CXCR2-KO PMNs were not observed in joint and CXCR2 ligands prevented SF neutrophils from undergoing apoptosis.

Conclusion: Our data demonstrate that C5a is the critical initiator of PMN adhesion on joint endothelium and is required to initiate joint inflammation in IC-induced arthritis. In addition, we have found that CCR1 contributes to the interaction of PMNs with the joint endothelium and that PMNs self-propagate their recruitment and survival via CXCR2 in the joint space.


Disclosure: Y. Miyabe, None; C. Miyabe, None; T. Murooka, None; E. Kim, None; N. Kim, None; T. R. Mempel, None; A. D. Luster, None.

To cite this abstract in AMA style:

Miyabe Y, Miyabe C, Murooka T, Kim E, Kim N, Mempel TR, Luster AD. Complement C5a Receptor Is the Key Initiator of Neutrophil Adhesion and Inflammation in Immune Complex-Induced Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/complement-c5a-receptor-is-the-key-initiator-of-neutrophil-adhesion-and-inflammation-in-immune-complex-induced-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/complement-c5a-receptor-is-the-key-initiator-of-neutrophil-adhesion-and-inflammation-in-immune-complex-induced-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology